China Cell Biology Industry Conference (CBIC)

July 16, 2026  Source: drugdu 38

"/

Organiser:Beijing Life Science and Technology Industry Association, Shanghai Biomedical Industry Association

Time:July 16–18, 2026

Address:Fuhua 3rd Road, Futian District, Shenzhen

Exhibition hall:Shenzhen Futian Convention & Exhibition Center

 

Product range:

Antibody drugs, stem cells and regenerative medicine, immune cell therapy, cell-based drugs, 3D cell culture, cellular multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, novel vaccines, gene therapy, oncolytic viruses, etc.

 

About CBIC:

The China Cell Biology Industry Conference (CBIC) and Biomedical Innovation Cooperation Conference will cover core topics including antibody drugs, stem cells and regenerative medicine, immune cell therapy, cell-based drugs, 3D cell culture, cellular multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, novel vaccines, gene therapy, and oncolytic viruses. The conferences will focus on cutting-edge biotech advances, clinical applications, industrialization processes, investment and financing opportunities, industry standardization, and emerging regulatory trends.
The biomedical industry is one of China’s key strategic emerging industries. Currently, China is the world’s second-largest pharmaceutical market after the United States, and is in a critical stage of strategic transformation from generic drugs to innovative drugs. Precision medicine is driving a revolution in drug R&D; gene technology and cell engineering are bringing transformative changes to disease treatment; medical devices are moving toward intelligence and standardization, providing new diagnostic and therapeutic tools. Emerging biomedical service sectors such as contract research organizations (CROs), contract manufacturing organizations (CMOs), third-party testing, and health management are continuously emerging and expanding. The biomedical industry is experiencing rapid growth.
By editor
Share: 
Read more on

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.